Articles From: Spectra Energy Partners Announces 29th Consecutive Quarterly Cash Distribution Increase to Spectrum Pharmaceuticals Highlights Clinical Data for Captisol-Enabled™ (Propylene Glycol-Free) Melphalan at the 2015 BMT Tandem Meeting


2015/2/4
Quarterly distribution increase of 1.25 cents to $0.58875 per unit HOUSTON , Feb.
Sign-up for Spectra Energy Partners Announces 29th Consecutive Quarterly Cash Distribution Increase investment picks
2015/2/4
HOUSTON , Feb.
Sign-up for Spectra Energy Partners Reports Fourth Quarter and Year-End 2014 Results investment picks
2015/2/4
By Angela Chen Spectra Energy Corp.
Sign-up for Spectra Energy Profits Rise on Western Canada Segment investment picks
2015/2/4
HOUSTON , Feb.
Sign-up for Spectra Energy Reports Fourth Quarter and Year-End 2014 Results investment picks
2015/1/22
HOUSTON , Jan.
Sign-up for Spectra Energy to Acquire Brazoria Interconnector Gas Pipeline investment picks
2014/12/16
http://media3.marketwire.com/docs/spectralLG.jpg TORONTO, ONTARIO --
Sign-up for Spectral Announces Effective Date of Name Change investment picks
2014/12/15
http://media3.marketwire.com/docs/spectralLG.jpg TORONTO, ONTARIO --
Sign-up for Spectral Announces Normal Course Issuer Bid investment picks
2015/1/26
http://media3.marketwire.com/logos/20141230-Spec200.jpg TORONTO, ONTARIO --
Sign-up for Spectral on Track for Potential Commercialization in the First Half of 2016 investment picks
2015/2/19
http://media3.marketwire.com/logos/20141230-Spec200.jpg TORONTO, ONTARIO --
Sign-up for Spectral Provides Update to Shareholders investment picks
2015/2/12
http://media3.marketwire.com/logos/20141230-Spec200.jpg TORONTO, ONTARIO --
Sign-up for Spectral to Present at the 20th International Conference on Advances in Critical Care Nephrology (AKI & CRRT) in San Diego investment picks
2015/2/26
SAN DIEGO, Feb.
Sign-up for SpectralNet(TM) Enables Transport of RF Content Anywhere, Over Any IP Network investment picks
2015/2/19
Stellarex DCB Acquisition Closed and Stellarex Launched in Europe COLORADO SPRINGS, Colo., Feb.
Sign-up for Spectranetics Achieves Fourth Quarter 2014 Revenue of $63.0 Million investment picks
2015/1/27
COLORADO SPRINGS, Colo., Jan.
Sign-up for Spectranetics Completes Acquisition of Stellarex(TM) Drug Coated Balloon Assets From Covidien investment picks
2014/12/4
COLORADO SPRINGS, Colo., Dec.
Sign-up for Spectranetics Outlines Growth Opportunities at Analyst & Investor Meeting investment picks
2015/2/5
COLORADO SPRINGS, Colo., Feb.
Sign-up for Spectranetics to Hold 2014 Fourth Quarter Financial Results Conference Call on February 19 investment picks
2014/12/29
COLORADO SPRINGS, Colo., Dec.
Sign-up for Spectranetics to Present at the J.P. Morgan 33rd Annual Healthcare Conference investment picks
2014/12/1
Spectrum Brands Holdings, Inc. (NYSE:SPB), a global consumer products company with market-leading brands, announced today that its wholly owned subsidiary Spectrum Brands, Inc. (“Spectrum Brands”) intends to offer $250 million aggregate principal amount of senior notes (the “Notes”) and enter into a new term loan facility in an aggregate principal amount of €150 million (the “New Term Loan Facility”). The Notes will be offered to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to non-U.S. buyers in accordance with Regulation S under the Securities Act.
Sign-up for Spectrum Brands Announces Intention to Offer Senior Notes and Enter Into a New Term Loan Facility investment picks
2014/12/1
Spectrum Brands Holdings, Inc. (NYSE: SPB) announced today that its wholly owned subsidiary Spectrum Brands, Inc. (“Spectrum Brands”) will sell U.S. $250 million aggregate principal amount of 6.125% Senior Notes due 2024 (the “Notes”) at a price of 100.00% of the par value.
Sign-up for Spectrum Brands Announces Pricing of Senior Notes Offering investment picks
2015/1/9
Spectrum Brands Holdings Inc. (SPB) said Friday Chief Executive David Lumley is planning to retire by the end of 205.
Sign-up for Spectrum Brands CEO Dave Lumely to retire before year end investment picks
2015/1/20
Spectrum Brands Holdings, Inc. (NYSE: SPB), a global and diversified consumer products company with market-leading brands, announced today it has acquired privately owned Salix Animal Health, LLC, the world’s leading and largest vertically integrated producer and distributor of premium, natural rawhide dog chews, treats and snacks with annual revenues of approximately $100 million.
Sign-up for Spectrum Brands Holdings Acquires Salix Animal Health, World’s Largest Vertically Integrated Rawhide Dog Treat Company investment picks
2014/12/31
Spectrum Brands Holdings, Inc. (NYSE:SPB), a global and diversified consumer products company with market-leading brands, announced today it has completed the acquisition of Procter & Gamble’s (NYSE: PG) European pet food business, consisting of the complementary IAMS® and Eukanuba® premium brands for dogs and cats.
Sign-up for Spectrum Brands Holdings Completes Acquisition of the European IAMS and Eukanuba Pet Food Business investment picks
2015/1/28
Spectrum Brands Holdings, Inc. (NYSE: SPB) announced today that its Board of Directors declared a quarterly dividend of $0.33 per share on the Company’s common stock, which is an increase of 10 percent compared to the previous quarterly dividend of $0.30 per share.
Sign-up for Spectrum Brands Holdings Increases Common Stock Dividend by 10 Percent to $0.33 Per Share, Declares Regular Quarterly Dividend investment picks
2015/2/4
Spectrum Brands Holdings, Inc. (NYSE: SPB), a global and diversified consumer products company with market-leading brands, today reported fiscal 2015 first quarter results for the period ended December 28, 2014, and reiterated its outlook for a sixth consecutive year of record financial performance in fiscal 2015.
Sign-up for Spectrum Brands Holdings Reports Fiscal 2015 First Quarter Results investment picks
2015/1/14
Spectrum Brands Holdings, Inc. (NYSE: SPB), a diversified and global consumer products company with market-leading brands, announced today it will release its fiscal 2015 first quarter financial results for the period ended December 28, 2014 after the markets close on Wednesday, February 4.
Sign-up for Spectrum Brands Holdings to Report Fiscal 2015 First Quarter Financial Results and Hold Conference Call and Webcast on February 4 investment picks
2015/2/26
Spectrum Brands Holdings, Inc. (NYSE:SPB) will debut a variety of home appliances from BLACK+DECKER™ and George Foreman® brands and personal care products under the Remington™ brand at the 2015 International Home + Housewares Show.
Sign-up for Spectrum Brands To Showcase Newest Products From Leading Consumer Brands At The 2015 International Home + Housewares Show investment picks
2015/2/17
Spectrum Pharmaceuticals (NasdaqGS: SPPI) , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced it will be hosting its fourth quarter 2014 financial results and analyst day in New York City on Friday, March 13, 2015 from 10:00 a.m. to 12:00 p.m. ET.
Sign-up for Spectrum Pharmaceuticals Announces Fourth Quarter 2014 Financial Results and Analyst Day investment picks
2014/12/26
Spectrum Pharmaceuticals (Nasdaq: SPPI) , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the approval of Captisol-Enabled Melphalan (CE-Melphalan) HCl for injection (propylene glycol-free) for use as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma.
Sign-up for Spectrum Pharmaceuticals Files a New Drug Application with the FDA for Captisol-Enabled™ (Propylene Glycol-Free) Melphalan investment picks
2014/12/5
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced key presentations of clinical and scientific data related to its products at the 56th Annual Meeting of the American Society of Hematology (ASH), being held in San Francisco, California, from December 6-9, 2014.
Sign-up for Spectrum Pharmaceuticals Highlights 11 Abstracts at the 56th Annual Meeting of the American Society of Hematology (ASH) in San Francisco, California, December 6-9, 2014 investment picks
2015/2/12
Spectrum Pharmaceuticals (NasdaqGS: SPPI) , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced results of a clinical study of Propylene Glycol (PG)-Free, Captisol-enabled Melphalan (CE Melphalan) Conditioning for Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Multiple Myeloma (MM). Spectrum filed a New Drug Application (NDA) for approval of CE-Melphalan in December 2014 and expects a decision from the Food and Drug Administration (FDA) by late 2015.
Sign-up for Spectrum Pharmaceuticals Highlights Clinical Data for Captisol-Enabled™ (Propylene Glycol-Free) Melphalan at the 2015 BMT Tandem Meeting investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Spectra Energy Partners Announces 29th Consecutive Quarterly Cash Distribution Increase to Spectrum Pharmaceuticals Highlights Clinical Data for Captisol-Enabled™ (Propylene Glycol-Free) Melphalan at the 2015 BMT Tandem Meeting
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent